Physician profile
Janet Pan
NPI 1801056676
$46,191.73
in general payments reported to CMS, 2019-2025
100 companies · $8,105 in 2025
The $8,105 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,305 · 2020: $5,340 · 2021: $6,218 · 2022: $6,396 · 2023: $6,939 · 2024: $7,889 · 2025: $8,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23K · Education: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22,579.44 |
| Education | $353.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $3,043.32 | 2019-2025 | Calquence, Imfinzi, Enhertu |
| Janssen Biotech, INC. | $2,754.61 | 2019-2025 | Darzalex, Tecvayli, Imbruvica |
| Novartis Pharmaceuticals Corporation | $2,419.31 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $2,107.60 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Incyte Corporation | $2,097.05 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Eisai INC. | $1,674.77 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,626.11 | 2019-2025 | Opdivo, Opdualag |
| Pfizer INC. | $1,615.30 | 2019-2025 | |
| Amgen INC. | $1,583.82 | 2019-2025 | Kyprolis, Lumakras, Blincyto |
| Celgene Corporation | $1,487.48 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Bayer Healthcare Pharmaceuticals INC. | $1,364.10 | 2019-2025 | |
| Seagen INC. | $1,219.73 | 2019-2025 | Tukysa, Tivdak, Padcev |
| Abbvie INC. | $1,193.27 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,179.10 | 2020-2025 | Jemperli, Ojjaara, Zejula |
| Astellas Pharma US INC | $1,152.56 | 2019-2025 | Xtandi, Vyloy, Padcev |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $1,102.98 | 2019-2025 | Cabometyx |
| Takeda Pharmaceuticals U.S.A., INC. | $1,077.95 | 2019-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Pharmacyclics LLC, An Abbvie Company | $1,003.47 | 2019-2023 | Imbruvica, Epkinly |
| Alexion Pharmaceuticals, INC. | $919.67 | 2019-2025 | Ultomiris |
| Lilly USA, LLC | $892.20 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Genentech USA, INC. | $867.73 | 2019-2025 | Tecentriq, Phesgo, Itovebi |
| Gilead Sciences, INC. | $825.57 | 2019-2025 | Trodelvy |
| Puma Biotechnology, INC. | $818.95 | 2019-2025 | Nerlynx |
| Array Biopharma INC | $788.15 | 2019-2025 | Mektovi, Braftovi, Lorbrena |
| Regeneron Healthcare Solutions, INC. | $684.01 | 2019-2025 | Libtayo |
| Daiichi Sankyo INC. | $623.78 | 2019-2025 | Enhertu, Datroway |
| Coherus Oncology, INC. | $546.51 | 2020-2025 | Loqtorzi |
| Genzyme Corporation | $543.23 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $538.83 | 2020-2025 | Xpovio |
| Beigene USA, INC. | $528.12 | 2021-2025 | Brukinsa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $437.81 | 2019-2025 | Gilotrif |
| Blueprint Medicines Corporation | $382.54 | 2020-2025 | Ayvakit |
| Emd Serono, INC. | $378.76 | 2019-2025 | Bavencio |
| Kite Pharma, INC. | $365.83 | 2020-2024 | Yescarta |
| Aveo Pharmaceuticals, INC. | $351.43 | 2021-2025 | Fotivda |
| Taiho Oncology, INC. | $295.24 | 2019-2025 | |
| Stemline Therapeutics INC. | $281.11 | 2019-2025 | Orserdu, Elzonris |
| Jazz Pharmaceuticals INC. | $273.47 | 2019-2025 | |
| Foundation Medicine, INC. | $273.28 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $273.14 | 2023-2025 | Orgovyx |
| Sobi, INC | $259.26 | 2021-2025 | |
| Myovant Sciences INC. | $252.71 | 2021-2022 | |
| Rigel Pharmaceuticals, INC. | $251.54 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Morphosys, US INC. | $229.67 | 2021-2023 | Monjuvi |
| Adc Therapeutics America, INC. | $228.10 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $196.37 | 2019-2025 | Onivyde, Somatuline Depot |
| Pharmaessentia USA Corporation | $186.05 | 2024-2025 | Besremi |
| Servier Pharmaceuticals LLC | $128.06 | 2021-2025 | |
| Amag Pharmaceuticals, INC. | $120.93 | 2019-2021 | |
| Tersera Therapeutics LLC | $111.83 | 2019-2025 | Zoladex |
| Beone Medicines USA, INC. | $110.54 | 2025 | Brukinsa |
| Agios Pharmaceuticals, INC. | $110.02 | 2019-2025 | Pyrukynd |
| Genmab U.S., INC. | $107.44 | 2023-2025 | Epkinly |
| Recordati_rare_diseases_inc. | $106.04 | 2024-2025 | Sylvant, Enjaymo |
| Sanofi-Aventis U.S. LLC | $99.95 | 2022 | |
| Immunogen, INC. | $94.89 | 2023 | Elahere |
| Pharmacosmos Therapeutics INC. | $91.25 | 2020-2025 | Monoferric |
| Clovis Oncology, INC. | $90.44 | 2019-2020 | |
| Deciphera Pharmaceuticals INC. | $88.86 | 2022-2023 | Qinlock |
| Adaptive Biotechnologies Corporation | $88.19 | 2022-2023 | Clonoseq |
| Dendreon Pharmaceuticals LLC | $84.30 | 2019-2021 | |
| Geron Corporation | $80.65 | 2025 | Rytelo |
| Teva Pharmaceuticals USA, INC. | $79.59 | 2019-2020 | |
| Dova Pharmaceuticals | $78.23 | 2019-2021 | |
| Octapharma USA, INC. | $74.30 | 2021-2023 | Panzyga |
| Ge Healthcare | $72.68 | 2021-2025 | |
| Iovance Biotherapeutics, INC. | $63.17 | 2025 | Amtagvi |
| Legend Biotech USA INC. | $60.32 | 2025 | Carvykti |
| Chiesi USA, INC. | $59.65 | 2020-2025 | Ferriprox |
| Kyowa Kirin, INC. | $56.33 | 2020-2025 | |
| Grifols USA, LLC | $53.27 | 2023-2024 | Gamunex-C |
| Apellis Pharmaceuticals, INC. | $49.43 | 2025 | Empaveli |
| Partner Therapeutics, INC. | $48.08 | 2019 | |
| Tesaro, INC. | $47.83 | 2019 | |
| Organon LLC | $46.66 | 2021 | |
| Fennec Pharmaceuticals, INC. | $43.81 | 2024-2025 | Pedmark, Fyarro |
| Secura Bio, INC. | $42.88 | 2019 | |
| Caris Mpi, INC. | $42.41 | 2025 | Mi Cancer Seek |
| Emmaus Medical, INC. | $39.35 | 2022-2024 | Endari |
| Tg Therapeutics, INC. | $36.77 | 2021-2022 | |
| Epizyme, INC. | $34.92 | 2022 | |
| West Therapeutics Development, LLC | $32.16 | 2019 | |
| Sun Pharmaceutical Industries INC. | $30.70 | 2024 | |
| Tempus Ai, INC | $29.48 | 2024 | |
| Springworks Therapeutics, INC. | $28.95 | 2025 | Ogsiveo |
| Syndax Pharmaceuticals, INC. | $28.84 | 2025 | |
| Helsinn Therapeutics (U.S.), INC. | $27.49 | 2019 | |
| Amneal Pharmaceuticals LLC | $26.56 | 2023 | Neulasta, Neupogen, Avastin |
| Myriad Genetic Laboratories, INC. | $26.34 | 2021 | |
| Sirtex Medical INC | $24.07 | 2020 | |
| G1 Therapeutics, INC. | $23.21 | 2022 | |
| Mylan Institutional INC. | $22.53 | 2019 | |
| Mirati Therapeutics, INC. | $21.00 | 2023 | Krazati |
| Csl Behring | $17.19 | 2023 | Afstyla, Idelvion |
| Alnylam Pharmaceuticals INC. | $16.97 | 2022 | |
| Novocure INC. | $15.39 | 2020 | |
| Shorla Oncology INC. | $15.12 | 2025 | |
| Eusa Pharma (US) LLC | $14.82 | 2021 | |
| Advanced Accelerator Applications | $13.55 | 2020 | |
| Spectrum Pharmaceuticals INC. | $13.11 | 2019 |
Drugs and devices associated with these payments
Imbruvica $1,052Keytruda $1,011Lenvima $864Darzalex $755Ultomiris $751Enhertu $647Epkinly $599Nubeqa $570Cabometyx $562Calquence $540Libtayo $519Reblozyl $502Tecvayli $475Tukysa $453Jakafi $447Xpovio $438Jaypirca $438Verzenio $438Lynparza $431Imfinzi $425Monjuvi $414Braftovi $403Mektovi $403Talvey $388Fruzaqla $372Xtandi $371Ibrance $366Opdivo $357Kisqali $340Orgovyx $332Brukinsa $288Xofigo $280Venclexta $280Jemperli $263Trodelvy $259Lorbrena $257Opdualag $255Pemazyre $254Fotivda $251Nerlynx $237Padcev $235Sarclisa $227Ojjaara $223Orserdu $221Zejula $219Ayvakit $215Pomalyst $205Erleada $204Tecentriq $203Tivdak $202Lonsurf $200Inqovi $200Besremi $186Zynlonta $182Adcetris $179Elrexfio $176Lutathera $175Elahere $174Udenyca $169Welireg $147Pluvicto $143Retevmo $141Rybrevant $141Zepzelca $139Alunbrig $136Inlyta $134Carvykti $132Scemblix $129Xalkori $126Rezlidhia $121Tavalisse $121Fabhalta $116Onivyde $111Somatuline Depot $111Vitrakvi $110Stivarga $110Loqtorzi $110Akeega $109Gilotrif $106Comirnaty $105Doptelet $100Talzenna $96.83Vyloy $96.40Ninlaro $89.59Sylvant $86.14Piqray $84.69Paxlovid $82.44Iclusig $81.77Pyrukynd $80.98Rytelo $80.65Ziihera $73.76Zoladex $73.48Bosulif $71.92Bavencio $67.88Tibsovo $67.14Vonjo $64.63Phesgo $64.47Promacta $64.27Itovebi $64.27Amtagvi $63.17
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.